Walnut, CA—Farlong Pharmaceutical is donating 10% of September sales from Lifeflower Breviscapine to the Alzheimer’s Foundation of America (AFA), according to the press release. Farlong’s donation—in honor of World Alzheimer’s Month—will support AFA’s mission of providing support, services, and education to individuals, families, and caregivers affected by Alzheimer’s disease and...
Walnut, CA—Farlong Pharmaceutical has completed a three-year clinical trial to determine the effects of Farlong NotoGinseng, according to a press release. The randomized, placebo-controlled, double-blind, parallel study was performed on 100 adults between December 2016 and June 2019. It sought to determine the effect of Farlong’s branded Panax notoginseng extract...
Austin, TX—The American Botanical Council (ABC) announced in a press release that Farlong Pharmaceutical, an herbal ingredient and supplement company based in California, adopted both notoginseng and lifeflower through ABC’s Adopt-an-Herb Program. Adoption helps ABC expand its nonprofit research and educational mission and keep its HerbMedPro database updated with the...
.webp?height=180&t=1781270413&width=212 "shutterstock_633794078 (1).jpg")